Cometriq and Escitalopram drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cometriq (cabozantinib s-malate) and Escitalopram (escitalopram oxalate). Common drug interactions include cystitis among females and diarrhoea among males.

The phase IV clinical study analyzes what interactions people have when they take Cometriq and Escitalopram. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Cometriq?

Cometriq has active ingredients of cabozantinib s-malate. eHealthMe is studying from 2,712 Cometriq users. Check the latest studies of Cometriq.

What is Escitalopram?

Escitalopram has active ingredients of escitalopram oxalate. It is often used in depression. eHealthMe is studying from 78,080 Escitalopram users. Check the latest studies of Escitalopram.

On Jul, 12, 2026

14 people who take Cometriq and Escitalopram together, and have interactions are studied.

Cometriq and Escitalopram drug interactions.

What are the common drug interactions of Cometriq and Escitalopram, by gender? *:

female:

Cystitis (inflammation of the wall of the bladder)
Death
Dehydration (dryness resulting from the removal of water)
Depressed mood
Diarrhoea
Acne (skin problems that cause pimples)
Adverse drug reaction
Fatigue (feeling of tiredness)
Gingival bleeding (bleeding gums)
Scab (a hard coating on the skin formed during the wound healing)

male:

Diarrhoea
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
Oropharyngeal pain
Rash maculo-papular (red area on the skin that is covered with small confluent bumps)
Adverse drug reaction
Dysphonia (speech disorder attributable to a disorder of phonation)
Glossodynia (a burning or painful sensation in the tongue)
Palmar-plantar erythrodysaesthesia syndrome (hand-foot syndrome)
Anorectal discomfort
Dysgeusia (disorder of the sense of taste)

What are the common drug interactions of Cometriq and Escitalopram, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Dysphonia (speech disorder attributable to a disorder of phonation)
Glossodynia (a burning or painful sensation in the tongue)
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
Platelet count decreased
Dehydration (dryness resulting from the removal of water)
Diarrhoea

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Death
Palmar-plantar erythrodysaesthesia syndrome (hand-foot syndrome)
Rash maculo-papular (red area on the skin that is covered with small confluent bumps)

60+:

Diarrhoea
Fatigue (feeling of tiredness)
Glossodynia (a burning or painful sensation in the tongue)
Oropharyngeal pain
Death

What are the existing conditions these people have? *

Thyroid Cancer: 8 people, 57.14%
Metastases To Lung (cancer spreads to lung): 3 people, 21.43%
Breast Cancer Female: 3 people, 21.43%
Metastases To Central Nervous System (cancer spreads to central nervous system): 2 people, 14.29%
Gastric Cancer (stomach cancer): 2 people, 14.29%
Renal Cell Carcinoma (a kidney cancer): 1 person, 7.14%
Lung Neoplasm Malignant (cancer tumour of lung): 1 person, 7.14%
Connective Tissue Neoplasm (tumour of connective tissue): 1 person, 7.14%
Breast Cancer: 1 person, 7.14%
Brain Neoplasm Malignant (brain cancer tumour): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Cometriq and Escitalopram?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously